Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis

Kidney International
M H MiettinenJ Mustonen

Abstract

Nephropathia epidemica (NE) is a hemorrhagic fever with renal syndrome caused by Puumala hantavirus. Its long-term prognosis is considered favorable. There are, however, some reports about subsequent hypertension, glomerular hyperfiltration, and proteinuria after previous hantavirus infection. Therefore, we studied 36 patients 5 and 10 years after acute NE, with 29 seronegative controls. Office blood pressure, ambulatory 24-h blood pressure (ABP), glomerular filtration rate (GFR), and proteinuria were examined. Hypertensive subjects were defined as those patients having increased ambulatory or office blood pressure, or receiving antihypertensive therapy. Office blood pressure was used to define hypertension only if ABP was not determined. At 5 years, the prevalence of hypertension was higher among NE patients than in controls (50 vs 21%, P=0.020). At 10 years, the difference between the groups was no more significant (39 vs 17%, P=0.098). Five years after NE, patients showed higher GFR (121+/-19 vs 109+/-16 ml/min/1.73 m(2), P=0.012) and urinary protein excretion (0.19 g/day, range 0.12-0.38 vs 0.14 g/day, range 0.09-0.24, P=<0.001) than controls. At 10 years, there were no more differences in GFR or protein excretion between t...Continue Reading

References

Oct 1, 1992·Journal of Virology·M N PensieroJ Hay
Jan 1, 1992·Nephron·D Kleinknecht, P E Rollin
Feb 1, 1987·Kidney International·C E Mogensen
Jan 1, 1993·Renal Failure·M ElisafK C Siamopoulos
Jan 1, 1994·Scandinavian Journal of Infectious Diseases·J MustonenA Vaheri
May 22, 1996·JAMA : the Journal of the American Medical Association·A W Cowley, R J Roman
Jun 1, 1997·Journal of the American Society of Nephrology : JASN·R E SchmiederF C Luft
Nov 27, 1999·Scandinavian Journal of Infectious Diseases·M Brummer-KorvenkontioA Vaheri
May 29, 2000·Scandinavian Journal of Infectious Diseases·B Settergren
Sep 30, 2000·Kidney International·S MäkeläA Pasternack
Jan 29, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ilpo Ala-HouhalaAmos Pasternack
Mar 22, 2002·The New England Journal of Medicine·Richard J JohnsonBernardo Rodriguez-Iturbe
Sep 1, 1960·Archives of Internal Medicine·M E RUBINIM E McDOWELL
Oct 3, 2003·The Lancet Infectious Diseases·Olli VapalahtiAntti Vaheri
Dec 4, 2003·The Lancet Infectious Diseases·Jan ClementMarc Van Ranst
Mar 26, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Hubert WongGuido Filler

❮ Previous
Next ❯

Citations

Apr 9, 2010·Clinical Microbiology Reviews·Colleen B JonssonOlli Vapalahti
Jun 24, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Christopher BoehlkeElke Neumann-Haefelin
May 5, 2012·Critical Reviews in Microbiology·Maria SargianouGeorge Panos
Nov 16, 2012·Kidney International·Ellen KrautkrämerAlexander Plyusnin
May 9, 2008·Reviews in Medical Virology·Antti VaheriAlexander Plyusnin
Aug 13, 2013·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Maja Martinuč BergočJernej Pajek
Jul 5, 2012·Reviews in Medical Virology·Antti VaheriOlli Vapalahti
Oct 14, 2011·Scandinavian Journal of Urology and Nephrology·Robert WagnerKarlheinz Seitz
Jul 21, 2010·Scandinavian Journal of Primary Health Care·Alette BrorstadClas Ahlm
Oct 16, 2013·Antiviral Research·Jukka MustonenAntti Vaheri
Dec 24, 2014·Emerging Infectious Diseases·Joerg LatusNiko Braun
Jan 5, 2017·Infectious Diseases·Jukka MustonenSatu Mäkelä
May 19, 2018·Emerging Infectious Diseases·Maxime HentzienAmélie Servettaz
Mar 4, 2009·Expert Review of Anti-infective Therapy·Paul HeymanTatjana Avsic-Zupanc
Dec 22, 2010·Expert Review of Anti-infective Therapy·Jonas Klingström, Clas Ahlm
Jun 1, 2008·NDT Plus·Katharina FriebeMarkus Krautter
May 14, 2019·Infectious Diseases·Maria FurbergBarbara Schumann
Aug 22, 2013·Deutsches Ärzteblatt International·Detlev H KrügerJörg Hofmann
Mar 21, 2017·Kidney International·Eric SiddallJai Radhakrishnan
Aug 5, 2021·Experimental and Therapeutic Medicine·Gabriela LupuşoruGener Ismail
Aug 29, 2021·Viruses·Antti VaheriJukka Mustonen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
S MäkeläJ Mustonen
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Misa KorvaTatjana Avsic-Zupanc
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
L PetterssonClas Ahlm
© 2022 Meta ULC. All rights reserved